Andrew Rockabrand
Drug Substance Site Molecule Steward/Development Scientist @ Eli Lilly and Company
About Andrew Rockabrand
Andrew Rockabrand serves as a Drug Substance Site Molecule Steward and Development Scientist at Eli Lilly, where he has worked since 2011. He specializes in drug substance downstream purification and has extensive experience in process profiling and regulatory documentation.